Market research remains a critical element for acquisition searches and due diligence. It projects a company’s future performance as reported by its customers thereby providing
The results showed an overwhelming number of both academic and industrial researchers across all geographic regions agreed
NGS service providers conservatively prepare five times the number of NGS libraries per week as those prepared by individual labs (those labs that don’t routinely provide NGS as a service).
Next generation sequencing (NGS) is a disruptive technology with an ever-increasing number of users and applications. As such, it is the fastest growing and most attractive segment of all the different technologies that comprise the genomics universe.
despite the buzz about “email going away,” our recent study found that 50% of life scientists prefer to receive new product information via email compared to other communication channels.
What does make a scientist click through, and what makes them hit delete? When are your customers most receptive to receiving emails from you?
In this complex macroeconomic environment, life science suppliers are seeking guidance as to how to anticipate market trends in the United States, Europe and Asia in the coming year.
Huge investments in physical infrastructure and human capital are being made in China, South Korea and Singapore. Japan’s international competitiveness has declined
Reduced federal funding affects not only current research budgets, but also future investments in infrastructure and training.
This infographic highlights a few key findings from a recent study, that shows performance as the most important attribute that drives customer satisfaction
Pay Invoice
Latest Blogs
-
8 Key Highlights: Conferences and Exhibit Strategies in the Life Sciences
March 12, 2024 12:08 pm
-
Choose Wisely: Should I Use Quantitative or Qualitative Market Research?
February 13, 2024 10:49 am
-
Winners of the 2021 Life Science Industry Awards for Innovation
December 9, 2021 12:13 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.